These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25625275)

  • 21. Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome sequencing study.
    Ren Y; Liu K; Kang X; Pang L; Qi Y; Hu Z; Jia W; Zhang H; Li L; Hu J; Liang W; Zhao J; Zou H; Yuan X; Li F
    Am J Transl Res; 2015; 7(11):2482-99. PubMed ID: 26807193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.
    Shi W; Hasimu G; Wang Y; Li N; Chen M; Zhang H
    Am J Transl Res; 2015; 7(10):1974-83. PubMed ID: 26692940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mtss1 is a critical epigenetically regulated tumor suppressor in CML.
    Schemionek M; Herrmann O; Reher MM; Chatain N; Schubert C; Costa IG; Hänzelmann S; Gusmao EG; Kintsler S; Braunschweig T; Hamilton A; Helgason GV; Copland M; Schwab A; Müller-Tidow C; Li S; Holyoake TL; Brümmendorf TH; Koschmieder S
    Leukemia; 2016 Apr; 30(4):823-32. PubMed ID: 26621336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTSS1: a multifunctional protein and its role in cancer invasion and metastasis.
    Xie F; Ye L; Ta M; Zhang L; Jiang WG
    Front Biosci (Schol Ed); 2011 Jan; 3(2):621-31. PubMed ID: 21196400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
    Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
    Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung.
    Kayser G; Csanadi A; Kakanou S; Prasse A; Kassem A; Stickeler E; Passlick B; Zur Hausen A
    Br J Cancer; 2015 Mar; 112(5):866-73. PubMed ID: 25625275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
    Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
    J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
    Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTSS1 is a metastasis driver in a subset of human melanomas.
    Mertz KD; Pathria G; Wagner C; Saarikangas J; Sboner A; Romanov J; Gschaider M; Lenz F; Neumann F; Schreiner W; Nemethova M; Glassmann A; Lappalainen P; Stingl G; Small JV; Fink D; Chin L; Wagner SN
    Nat Commun; 2014 Mar; 5():3465. PubMed ID: 24632752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration.
    Zhong J; Shaik S; Wan L; Tron AE; Wang Z; Sun L; Inuzuka H; Wei W
    Oncotarget; 2013 Dec; 4(12):2339-53. PubMed ID: 24318128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.
    Wang F; Liu Y; Zhang H
    Pathol Oncol Res; 2013 Oct; 19(4):815-20. PubMed ID: 23852458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.
    Kayser G; Csanadi A; Otto C; Plönes T; Bittermann N; Rawluk J; Passlick B; Werner M
    PLoS One; 2013; 8(2):e56333. PubMed ID: 23418554
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.